Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$16.06 - $26.39 $739,996 - $1.22 Million
46,077 Added 41.29%
157,681 $2.68 Million
Q1 2022

May 13, 2022

SELL
$28.19 - $46.6 $61,566 - $101,774
-2,184 Reduced 1.92%
111,604 $4.13 Million
Q4 2021

Feb 14, 2022

BUY
$41.2 - $73.6 $3.23 Million - $5.76 Million
78,288 Added 220.53%
113,788 $5.18 Million
Q4 2020

Feb 12, 2021

SELL
$41.43 - $77.09 $393,585 - $732,355
-9,500 Reduced 21.11%
35,500 $2.57 Million
Q3 2020

Nov 16, 2020

BUY
$30.88 - $37.94 $308,800 - $379,400
10,000 Added 28.57%
45,000 $1.71 Million
Q2 2020

Aug 13, 2020

BUY
$18.95 - $35.43 $663,250 - $1.24 Million
35,000 New
35,000 $1.24 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Formula Growth LTD Portfolio

Follow Formula Growth LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Formula Growth LTD, based on Form 13F filings with the SEC.

News

Stay updated on Formula Growth LTD with notifications on news.